Skip to main content
Equibles

BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1520354 Paris, I0
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,665,023
+$4,904,802 QoQ
Shares Held
409,255
-2.1% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 311 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,299,463 across 137 Biotechnology names. RARE ranks #29 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 897,893 $446,010,389
2 REGN
Regeneron Pharmaceuticals, Inc.
 331,560 $206,740,921
3 JAZZ
Jazz Pharmaceuticals plc
 799,297 $192,606,596
4 ARGX
Argenx SE
 121,786 $112,989,396
5 INCY
Incyte Corp
 937,763 $106,304,813
6 XENE
Xenon Pharmaceuticals Inc.
 1,290,731 $77,908,522
7 VCEL
Vericel Corp
 1,639,988 $72,963,065
8 CYTK
Cytokinetics Inc
 827,810 $70,521,132

All Filings in RARE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,665,023 409,255
2026-03-31 $8,760,221 418,149
2025-12-31 $43,692,203 1,899,661
2025-09-30 $46,481,991 1,545,279
2025-06-30 $52,799,446 1,452,130
2025-03-31 $41,658,011 1,150,456
2024-12-31 $40,306,298 958,077
2024-09-30 $40,228,309 724,182
2024-06-30 $34,128,412 830,375
2024-03-31 $23,676,265 507,095
2023-12-31 $3,950,840 82,619
2022-06-30 $485,572 8,139